Search Results - "Augis, Vanessa"

Refine Results
  1. 1

    A single nucleotide polymorphism in cBIM is associated with a slower achievement of major molecular response in chronic myeloid leukaemia treated with imatinib by Augis, Vanessa, Airiau, Kelly, Josselin, Marina, Turcq, Béatrice, Mahon, François-Xavier, Belloc, Francis

    Published in PloS one (05-11-2013)
    “…BIM is essential for the response to tyrosine-kinase inhibitors (TKI) in chronic myeloid leukaemia (CML) patients. Recently, a deletion polymorphism in intron…”
    Get full text
    Journal Article
  2. 2

    Beta‐thalassaemia intermedia due to a complex alpha‐globin rearrangement and a heterozygous beta thalassaemia mutation by Marin, Victor, Huguenin, Yoann, Bessi, Lucile, Weinmann, Laurent, Augis, Vanessa, Desclaux, Arnaud, Lebreton, Louis, Dulucq, Stephanie, Boutin, Julian

    Published in British journal of haematology (01-11-2024)
    “…The alpha‐thalassaemia alleles are very frequent in the world's population. The main molecular mechanism is a large deletion with the loss of one or two alpha…”
    Get full text
    Journal Article
  3. 3

    Beta-thalassemia intermedia due to a complex alpha-globin rearrangement and a heterozygous beta thalassemia mutation by Marin, Victor, Huguenin, Yoann, Bessi, Lucile, Weinmann, Laurent, Augis, Vanessa, Desclaux, Arnaud, Lebreton, Louis, Dulucq, Stephanie, Boutin, Julian

    Published in British journal of haematology (18-08-2024)
    “…The alpha-thalassaemia alleles are very frequent in the world's population. The main molecular mechanism is a large deletion with the loss of one or two alpha…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    A Single Nucleotide Polymorphism in the Coding Sequence of BIM Is Associated with Poor Prognostic in Chronic Myeloid Leukaemia Treated by Imatinib by Mahon, Francois-Xavier, Augis, Vanessa, Airiau, Kelly, Josselin, Marina, Turc, Beatrice, Belloc, Francis

    Published in Blood (16-11-2012)
    “…Abstract 1683 BIM is a pro-apoptotic protein essential to tyrosine kinase inhibitors (TKI) response in chronic myeloid leukaemia (CML) patients. Thus,…”
    Get full text
    Journal Article
  11. 11

    Déterminations de groupes sanguins au CHU de Bordeaux : et maintenant que fait-on ? by Pujol, Sophie, Roger, Isabelle, Dubois, Marie, Signac, Evelyne, Sauvage, Anne, Puntous, Maryse, Augis, Vanessa, Descamps, Celine

    “…L’enquête socio-cognitive multicentrique menée en 2016 sur la réalisation des deux déterminations de groupe sanguin (H. Gouezec, TCB 09/2017) a permis de…”
    Get full text
    Journal Article
  12. 12

    Expérience de réattribution assistée de PSL (hors dépôt relais) par l’EFS-NVAQ (sites de Bordeaux et Haut-Lévèque), au CHU de Bordeaux by Puntous, Maryse, Levoir, Laure, Pujol, Sophie, Béguet-Yachine, Mathilde, Roger, Isabelle, Augis, Vanessa

    “…Pour ne pas détruire des PSL conformes, et respecter chaque don en toute sécurité, l’unité de sécurité transfusionnelle et d’hémovigilance du CHU de Bordeaux…”
    Get full text
    Journal Article
  13. 13

    Groupe sanguin à tout prix » : atelier d’apprentissage par l’erreur by Signac, Evelyne, Sauvage, Anne, Dubois, Marie-Chantal, Descamps, Celine, Puntous, Maryse, Pujol, Sophie, Roger, Isabelle, Augis, Vanessa

    “…Un atelier réflexif et ludique a été réalisé dans le cadre de la 22e Journée régionale d’hémovigilance et de sécurité transfusionnelle organisée par le CHU de…”
    Get full text
    Journal Article
  14. 14
  15. 15

    A Single Nucleotide Polymorphism in Pro-Apoptotique Protein BIM Affects Chronic Myeloid Leukaemia Evolution during Imatinib Treatment by Augis, Vanessa, Belloc, Francis, Airiau, Kelly, Chollet, Claudine, Mahon, Francois-Xavier

    Published in Blood (16-11-2008)
    “…The tyrosin kinase inhibitor imatinib induces apoptosis in chronic myeloid leukaemia (CML) cells. RNA interference experiments have demonstrated that the…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib: e78582 by Augis, Vanessa, Airiau, Kelly, Josselin, Marina, Turcq, Beatrice, Mahon, Francois-Xavier, Belloc, Francis

    Published in PloS one (01-11-2013)
    “…Purpose BIM is essential for the response to tyrosine-kinase inhibitors (TKI) in chronic myeloid leukaemia (CML) patients. Recently, a deletion polymorphism in…”
    Get full text
    Journal Article
  19. 19
  20. 20